Clinical Trials on Moderate to Severe Chronic Periodontitis
Total 1335 results
-
KLOX Technologies Inc.CompletedModerate to Severe Chronic PeriodontitisCanada
-
Columbia UniversityCompletedPeriodontal Diseases | Generalized Moderate Chronic Periodontitis | Generalized Severe Chronic PeriodontitisUnited States
-
Koite Health OyLithuanian University of Health Sciences; University of HelsinkiRecruitingPeriodontitis Chronic Generalized Moderate | Periodontitis Chronic Generalized SevereLithuania
-
Virginia Commonwealth UniversityWithdrawnPeriodontitis Chronic Generalized Moderate | Periodontitis Chronic Generalized SevereUnited States
-
University of California, Los AngelesBiolase IncCompletedPeriodontitis Chronic Generalized Moderate | Periodontitis Chronic Generalized Severe
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
Aqpha Medical B.V.Not yet recruitingModerate to Severe Nasolabial Fold
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Galderma R&DCompletedModerate to Severe Glabellar LinesChina
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
AllerganCompletedModerate to Severe Nasolabial FoldsGermany, Netherlands
-
JHM BioPharma (Tonghua) Co. , Ltd.Recruiting
-
AbbVieCompletedModerate to Severe Glabellar LinesJapan
-
Chongqing Claruvis Pharmaceutical Co., Ltd.CompletedModerate to Severe Glabellar LinesChina
-
Croma-Pharma GmbHCompleted
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Merz North America, Inc.CompletedModerate to Severe Midface Volume DeficitCanada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
University of NebraskaCompletedModerate to Advanced Chronic PeriodontitisUnited States
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Janssen PharmaceuticaWithdrawnModerate to Severe Chronic Non-cancer Pain
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Mundipharma Research GmbH & Co KGCompletedSubjects With Moderate to Severe, Chronic Nonmalignant Pain
-
Xinhua Hospital, Shanghai Jiao Tong University...TerminatedASD Accompanied by Moderate to Severe Gastrointestinal SymptomsChina
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial Folds (NLFs)China
-
Merz North America, Inc.CompletedCorrection of the Moderate to Severe Nasolabial FoldsChina
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisChina
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
Dong-A ST Co., Ltd.Meiji Seika Pharma Co., Ltd.CompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Novartis PharmaceuticalsActive, not recruitingModerate to Severe Chronic Plaque PsoriasisChina
-
AbbVie (prior sponsor, Abbott)IMS HealthCompletedModerate-to-severe Chronic Plaque Psoriasis
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
CelltrionRecruitingModerate to Severe Chronic Plaque PsoriasisEstonia